Naoko Takebe to Leukemia, Myeloid, Acute
This is a "connection" page, showing publications Naoko Takebe has written about Leukemia, Myeloid, Acute.
Connection Strength
0.744
-
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute. J Clin Oncol. 2022 06 10; 40(17):1949-1957.
Score: 0.744